Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of hepatocellular carcinoma.

× No keyword cloud information.

40 in total

1. CCL5-28, CCL5-403, and CCR5 genetic polymorphisms and their synergic effect with alcohol and tobacco consumptions increase susceptibility to hepatocellular carcinoma.

Authors: Hsiu-Ting Tsai; Shun-Fa Yang; Dar-Ren Chen; Szu-Erh Chan
Journal: Med Oncol Date: 2012-02-29 Impact factor: 3.064

2. Estimate or calculate? How surgeons rate volumes and surfaces.

Authors: Jochen Schuld; Otto Kollmar; Roland Seidel; Catherine Black; Martin K Schilling; Sven Richter
Journal: Langenbecks Arch Surg Date: 2012-03-17 Impact factor: 3.445

3. Phase 2 study of bevacizumab plus erlotinib in patients with advanced hepatocellular cancer.

Authors: Philip A Philip; Michelle R Mahoney; Kyle D Holen; Donald W Northfelt; Henry C Pitot; Joel Picus; Patrick J Flynn; Charles Erlichman
Journal: Cancer Date: 2011-09-27 Impact factor: 6.860

4. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

Authors: A Grieco; M Pompili; G Caminiti; L Miele; M Covino; B Alfei; G L Rapaccini; G Gasbarrini
Journal: Gut Date: 2005-03 Impact factor: 23.059

5. Combined TACE and PEI for palliative treatment of unresectable hepatocellular carcinoma.

Authors: Gerhild Becker; Tarik Soezgen; Manfred Olschewski; Joerg Laubenberger; Hubert Erich Blum; Hans-Peter Allgaier
Journal: World J Gastroenterol Date: 2005-10-21 Impact factor: 5.742

6. Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis--a randomized study.

Authors: Q Li; J Wang; Y Sun; Y L Cui; J T Juzi; H X Li; B Y Qian; X S Hao
Journal: World J Surg Date: 2006-11 Impact factor: 3.352

7. Liver transplantation for hepatocellular carcinoma: the ochsner experience.

Authors: George E Loss; Satheesh Nair; Jamie L Blazek; Gist H Farr; James D Eason
Journal: Ochsner J Date: 2002

8. Indication of hepatectomy for cirrhotic patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors: Hideki Nakahara; Toshiyuki Itamoto; Koji Katayama; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Hirotaka Tashiro; Toshimasa Asahara
Journal: World J Surg Date: 2005-06 Impact factor: 3.352

9. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors: Yung-Chih Lai; Cheng-Yen Shih; Chin-Ming Jeng; Sien-Sing Yang; Jui-Ting Hu; Yung-Chuan Sung; Han-Ting Liu; Shaw-Min Hou; Chi-Hwa Wu; Tzen-Kwan Chen
Journal: World J Gastroenterol Date: 2003-12 Impact factor: 5.742

10. The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.

Authors: Hwan Jun Jae; Jin Wook Chung; Hee Sun Park; Min Jong Lee; Ki Chang Lee; Hyo-Cheol Kim; Jung Hwan Yoon; Hesson Chung; Jae Hyung Park
Journal: Korean J Radiol Date: 2009 Nov-Dec Impact factor: 3.500